MINI LONG - MERCK & CO. Share Price

Certificat

DE000KJ3BHL0

Market Closed - Boerse Frankfurt Warrants 11:09:28 12/06/2024 pm IST
2.67 EUR -2.20% Intraday chart for MINI LONG - MERCK & CO.
Current month+23.04%
1 month-1.84%
Date Price Change
12/24/12 2.67 -2.20%
11/24/11 2.73 +2.25%
10/24/10 2.67 +0.38%
07/24/07 2.66 +4.31%
06/24/06 2.55 -0.39%

Real-time Boerse Frankfurt Warrants

Last update June 12, 2024 at 11:09 pm IST

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Citi Citi
WKN KJ3BHL
ISINDE000KJ3BHL0
Date issued 04/01/2024
Strike 102.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.02
Lowest since issue 1.45

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
142.7 USD
Spread / Average Target
+9.59%
Consensus